SCHEMBL22889381

SCHEMBL22889381

c1ccc(-c2cccc(-c3ccc4cccc(-c5nc(-c6ccc(-c7ccc8ccccc8c7)cc6)nc(-c6cccc7c6oc6ccccc67)n5)c4c3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 3/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 4/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 2/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21304725 0.99 ALOX5 (0.43) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889128 0.98 ALOX5 (0.43) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889125 0.97 ALOX5 (0.43) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889403 0.97 ALOX5 (0.45) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL21304726 0.95 ALOX5 (0.46) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889267 0.95 ALOX5 (0.46) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22888614 0.94 ALOX5 (0.44) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL21304198 0.94 ALOX5 (0.47) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889077 0.94 ALOX5 (0.47) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2
SCHEMBL22889190 0.94 ALOX5 (0.47) ALOX5ALDH1A1KDM4ETP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885ALDH1A1 1387/4885KDM4E 1801/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885ALDH1A1 1441/4885KDM4E 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.